Sort   by:  
 Page size 
UnknownSerotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.
Not available
S-EPMC6141614 | biostudies-literature
UnknownDetailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Not available
S-EPMC5470078 | biostudies-literature
UnknownEmetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
Not available
S-EPMC5029623 | biostudies-literature
UnknownBone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis.
Not available
S-EPMC6355484 | biostudies-literature
UnknownThe expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
Not available
S-EPMC4635188 | biostudies-literature
UnknownThe lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Not available
S-EPMC4741628 | biostudies-literature
UnknownPrognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1.
Not available
S-EPMC8945292 | biostudies-literature
UnknownIncidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Not available
S-EPMC10188633 | biostudies-literature
UnknownDiverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Not available
S-EPMC11724937 | biostudies-literature
UnknownSurvival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Not available
S-EPMC10162955 | biostudies-literature
Sort   by:  
 Page size